The Evolving Landscape of Prostate Cancer Management: BRCA Testing and ctDNA as Diagnostic Tools and PSMA-Imaging and -Targeted Approaches.
- Published in:
- Oncology (08909091), 2024, v. 38, n. 10, p. 387
- By:
- Publication type:
- Article
Works matching IS 08909091 AND DT 2024 AND VI 38 AND IP 10
Results: 6
1
2
Linvoseltamab Still Efficacious Despite CRL in Multiple Myeloma.
- Published in:
- Oncology (08909091), 2024, v. 38, n. 10, p. 384
- By:
- Publication type:
- Article
3
Expert Commentary on the Product Pro? le of Lazertinib in NSCLC.
- Published in:
- Oncology (08909091), 2024, v. 38, n. 10, p. 381
- By:
- Publication type:
- Article
4
Hereditary Renal Tumor Syndromes and the Use of mTOR Inhibitors.
- Published in:
- Oncology (08909091), 2024, v. 38, n. 10, p. 376, doi. 10.46883/2024.25921027
- By:
- Publication type:
- Article
5
Cancer Rehabilitation Medicine: "Bridging the Gap" With Supportive Care.
- Published in:
- Oncology (08909091), 2024, v. 38, n. 10, p. 372
- By:
- Publication type:
- Article
6
Breast Cancer Breakthroughs: 2024 ESMO Highlights.
- Published in:
- Oncology (08909091), 2024, v. 38, n. 10, p. 371
- By:
- Publication type:
- Article